广告和GLP-1优惠:认证,限制条款和禁令触发

您可以运行Google广告,提供semaglutide或tirzepatide?

Yes, within two separate lanes. Google's restricted drug terms policy lets any advertiser targeting the US, Canada or New Zealand use prescription drug terms in ad text and landing pages without certification — but keyword-targeting those same terms is a different matter entirely. Google states plainly that "you must be certified in order to keyword-target these terms," which means bidding on "tirzepatide" or "Ozempic" as a search term requires certification most supplement and info-product sellers cannot obtain.

Certification runs through two gatekeepers. Online pharmacies need LegitScript Healthcare Merchant Certification or NABP accreditation; telemedicine providers need LegitScript certification specifically. Either way, Google adds a second layer on top — the advertiser must also hold Google's own certification before the account can bid on restricted terms. Working through LegitScript certification for GLP-1 telehealth before you touch keyword strategy saves months of wasted spend chasing a certification you don't yet have.

Google's prescription drug reference list is not exhaustive, but it does name names: semaglutide, tirzepatide, liraglutide, Ozempic, Wegovy, Mounjaro and Zepbound all appear on it explicitly. That list matters for classification. A product sharing a molecule name with an approved drug gets treated as a prescription drug term regardless of who is selling it, compounded pharmacy or brand manufacturer alike.

克斯克斯克斯克斯需要什么证书?

Google 要求两份证书堆叠在一起,而不是一个.第一证明业务是合法的.

果和果 (Meta和TikTok 运行并行但不是相同的手套,

广告副本和登陆页面中,哪些药物术语是限制的?

限制药物术语涵盖处方药的分子和品牌名称.Google列表公布了半胺,铁塞巴泰,里拉格鲁泰,奥泽米奇,韦戈维,穆恩贾罗和泽波安的名称,Google将其视为不完全.在美国,加拿大和新西兰,您可以在广告副本和登陆页面上打印这些单词,而不需认证.您不能购买关键字.

另外,Google的医疗保健和药品政策中,完全禁止特定成分类别,无论是否具有认证状态:

• 含有酸盐的产品
• 含有人体胆固醇 (hCG) 的产品,用于减肥或控制体重
• 含有活性药物或危险成分的草药和饮食补充剂

减肥补充剂可以投标Ozempic和GLP-1关键字吗?

对于关键字本身的竞标需要认证,补充剂或研究酸卖家结构上无法获得,因为Google保留了在线药店,远程医疗提供商和制药厂商的认证.无论如何,尝试,关键字目标执行者甚至在创意得到审查之前就会抓住广告.

Even reference-only copy runs into a second wall. Google's unapproved substances policy bans, "regardless of any claims of legality," products that "imply they are as effective as prescription drugs" — the exact trap a "natural Ozempic" or "GLP-1 alternative" headline sets for itself. Before writing that headline, pull the field through the Google Ads Transparency Center and see what language actually survived review versus what got pulled.

The FDA layer compounds the risk rather than replacing it. Under 21 CFR 101.93(g)(2), naming a prescription drug in supplement labeling is itself evidence of an implied disease claim, and section (g)(2)(iv)(B) specifically flags an ingredient "well known to consumers for its use or claimed use in preventing or treating a disease" — precisely what "for Ozempic users" or "eases GLP-1 side effects" positioning does. Testing angles with AI UGC ad tools for supplement offers doesn't fix this; the claim itself is the liability, not the production value behind it.

那些不经过认证的广告商提到毒品名称会发生什么?

没有关键字目标的引用仍然是一个常规的政策问题,而不是帐户的死刑.在体内副本中提到"tirzepatide"而不投标作为关键字,如果有,执行是不批准个人广告或限制关键字资格不是自动的帐户暂停,与许多机构恐吓副本所 implies相反.

实际上帐户死亡的是在逃避,而不是提到.Google的滥用广告网络政策将"绕过系统"和"逃避广告内容"视为严重的违规行为,后者定义为操纵广告组件,如文字,图像,域或子域以绕过检测.Google表示"您的Google广告帐户将在检测后暂停,并且没有预警,您将不得再使用Google广告进行广告."转换域以避免药物禁用是政策确实存在的模式.

检查是否会升级的不认可从检查实际现场开始. 拉取帐户的模式与类似广告商正在运行的通过 如何看到竞争对手的Google广告 之前假设一个不认可的广告意味着帐户处于暂停倒计.

医疗保健认证需要多长时间,它涵盖什么?

据悉,Google并没有发布LegitScript-plus-Google认证的固定时间表,因此您从机构那里听到的任何特定日数都应该被视为未经验证而不是确认的政策.

认证涵盖两个不同的东西,而不是一个.LegitScript或NABP层验证了底层的业务,产品合法性,处方实践,而Google的自己的广告商认证实际上授权了限制术语的关键字目标,一旦第一层已经在位.Google也在扩大其广告商验证计划,最终要求所有广告商验证,并在该过程中提交虚假信息,其本身被视为绕过系统的违规.

什么让一个健康领域永久停职?

绕系统获得永久性,Google在一句话中说:被捕的账户操纵文字,图像,域或子域以绕过检测"在检测后被暂停,并且没有预警,

协调欺骗实践和不可接受的商业实践与绕过系统相同的严重违规层次,这意味着在没有正常的误报小部分,如不靠谱的索赔或点击诱惑广告所获得的警告期即时暂停. 目的地不匹配 显示URL域不匹配最终登陆页面 是隐藏补充道内部的常见触发器,Google的 AdsBot爬虫检查功能,而不是荣誉系统.

For accounts still inside the ordinary appeal path, the mechanics are procedural: file through Policy Manager, expect roughly 24 hours for initial review, and know the cap sits at 3 appeals per ad. Starting July 21, 2026, Google stopped accepting direct appeals for decisions older than 6 months, so a disapproval left unaddressed for half a year becomes effectively permanent by default. Working through what actually reverses a Google Ads misrepresentation suspension beats guessing at which lever to pull.

快速决策检查列表

实际问题是,读者是否需要更快的证据来了解已经在VSL驱动的直接反应中发挥作用,特别是在营养品,补充剂,GLP-1,减肥,血糖以及相邻的高意向健康市场上.

对于下一个决定,最重要的是根据市场活动的例子:哪个子要测试,哪个索赔风格有风险,哪个道结构是常见的,哪个语言市场正在移动,以及竞争对手的创意是否可能是早期,扩展或已经和.

• 如果您需要直接答案,请从TL;DR开始.
• 快速比较交易.
• 使用常见问题,以提供答案机准备的总结.
• 根据该决定,使用CTA,而不是理论,需要实时VSL和广告示例.

报道报道报道报道报道报道报道报道报道报道报道报道

广告客户在视觉创意之外所做的事情理解的环境,包括广告客户在黑帽,灰帽和白帽广告模式中,具有足够的背景.实际的区别是,用户不仅看到屏幕截图;他们正在看到VSL,广告,道,转录,UTM文本和将资产转化为决定的研究笔记.

这很重要,因为直接响应的附属公司并不属于一个清洁类别.减肥活动可能使用白帽合规广告,灰帽预登陆器,更具侵略性的VSL和围绕上和恢复设计的收购路径.有用的智能平台需要捕获这种频谱,而不是假装每一次获胜的活动都像公共品牌广告.

黑帽,白帽和多语言信号覆盖

每日英特尔追踪黑帽和白帽式运动的模式,以便运营商能够理解市场而不盲目复制风险.白帽的例子有助于耐用性和合规性审查;黑帽和灰帽的例子揭示了压力点,子,机制和道结构,这些机制可能会推动支出,但需要在使用前仔细的适应.

该目录也为全球运营商构建,VSL和广告引用涵盖14多种语言和不同的当地语法.这对于巴西,拉塔姆,欧洲,MENA,印度和非原生英语附属公司来说是一个关键优势,他们需要看到市场的相同愿望如何跨文化转化,而不是仅仅研究美国英语广告.

如何负责任地使用情报

目标是建模,而不是复制. 使用每日英特尔来了解结构:,机制,证明,要求强度,深度,提供经济学和和阶段.然后构建原创创意,审查要求,并适应角度流量来源,国家,语言和合规要求的竞选.

强大的工作流程在行动之前比较多个例子.如果同一机制在多种语言,多种广告商和多种道变体中出现,它可能是持久的市场信号.如果这个例子只出现一次或依赖于攻击性索赔,请把它视为研究线索而不是竞选模板.

• 模型结构,而不是保护的创意资产.
• 单独的白帽耐用性与黑帽说服压力.
• 比较美国英语的例子与拉塔姆,欧洲和其他语言变体.
• 通过转录和接笔来构建原始简单.
• 保持合规性审查与市场研究分开.

方法论与来源背景

Daily Intel pages are written from a research workflow that reviews active VSLs, Meta ad creatives, transcripts, UTMs, funnel paths, checkout steps, upsells, recovery sequences, and compliance-sensitive claim patterns. The goal is to explain observable market behavior, not to provide legal, medical, or platform policy advice.

When the topic touches health claims, platform policy, or GLP-1 market research, validate the observable campaign signals against primary references such as FDA human drug compounding, FTC health claims guidance, and Meta advertising standards. Daily Intel adds the proprietary direct-response layer by mapping how those rules show up in active VSLs, Meta creatives, funnels, transcripts, UTMs, and checkout paths.

For deeper evaluation, continue through Nutra niche intelligence directory, Herbal Prozac, Nature's Adderall: Substitute Claims, Why 'Results Not Typical' Stopped Protecting Ads, Your Money-Back Guarantee Wording Is a Claim, Anti-Aging's Floor: Alzheimer's, Osteoporosis, Glaucoma, and What is a VSL?. These related Daily Intel pages connect this topic to the relevant methodology, pricing, trust context, comparison path, or niche workflow.